Latest Insider Transactions at Rhythm Pharmaceuticals, Inc. (RYTM)
This section provides a real-time view of insider transactions for Rhythm Pharmaceuticals, Inc. (RYTM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RHYTHM PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RHYTHM PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 09
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
15,572
-17.75%
|
$1,199,044
$77.41 P/Share
|
|
Jul 09
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,572
+19.4%
|
$264,724
$17.08 P/Share
|
|
Jul 09
2025
|
Christopher Paul German Corporate Controller & CAO |
SELL
Open market or private sale
|
Direct |
3,817
-54.12%
|
$305,360
$80.88 P/Share
|
|
Jul 09
2025
|
Christopher Paul German Corporate Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,850
+24.59%
|
$94,050
$33.6 P/Share
|
|
Jul 09
2025
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
7,969
-28.04%
|
$613,613
$77.78 P/Share
|
|
Jul 09
2025
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,969
+32.6%
|
$47,814
$6.8 P/Share
|
|
Jul 09
2025
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
42,120
-9.52%
|
$3,285,360
$78.68 P/Share
|
|
Jul 09
2025
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
42,120
+20.94%
|
$252,720
$6.88 P/Share
|
|
Jul 07
2025
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,986
+5.64%
|
$41,916
$6.88 P/Share
|
|
Jul 02
2025
|
Alastair Garfield Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,319
-14.87%
|
$84,416
$64.7 P/Share
|
|
Jul 01
2025
|
Alastair Garfield Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,445
+50.0%
|
-
|
|
Jun 18
2025
|
Edward T Mathers |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 18
2025
|
Stuart A Arbuckle Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 18
2025
|
Camille L Bedrosian Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 18
2025
|
Jennifer L Good Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 18
2025
|
Christophe Jean Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 18
2025
|
Lynn A. Tetrault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 18
2025
|
David W J Mcgirr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+36.36%
|
-
|
|
Jun 10
2025
|
Christopher Paul German Corporate Controller & CAO |
SELL
Open market or private sale
|
Direct |
2,069
-52.27%
|
$138,623
$67.19 P/Share
|
|
Jun 10
2025
|
Christopher Paul German Corporate Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,069
+21.27%
|
$18,173
$17.97 P/Share
|
|
Jun 06
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,031
-26.8%
|
$478,108
$68.05 P/Share
|
|
Jun 06
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,031
+21.13%
|
$42,186
$6.8 P/Share
|
|
Jun 03
2025
|
David P Meeker President and CEO |
SELL
Open market or private sale
|
Direct |
43,620
-8.9%
|
$2,835,300
$65.32 P/Share
|
|
Jun 03
2025
|
David P Meeker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,620
+15.09%
|
$174,480
$4.59 P/Share
|
|
Jun 03
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
65,431
-78.94%
|
$4,253,015
$65.4 P/Share
|
|
Jun 03
2025
|
David W J Mcgirr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,431
+48.88%
|
$261,724
$4.59 P/Share
|
|
May 30
2025
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,400
-9.02%
|
$1,427,400
$61.23 P/Share
|
|
May 30
2025
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,400
+14.93%
|
$140,400
$6.88 P/Share
|
|
Apr 29
2025
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
6,745
-15.19%
|
$438,425
$65.08 P/Share
|
|
Apr 29
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
7,031
-26.8%
|
$457,015
$65.09 P/Share
|
|
Apr 29
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,031
+21.13%
|
$42,186
$6.8 P/Share
|
|
Apr 15
2025
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
11,405
+20.44%
|
-
|
|
Apr 14
2025
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
10,375
+23.92%
|
-
|
|
Apr 08
2025
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
17,750
-25.03%
|
$1,065,000
$60.96 P/Share
|
|
Apr 08
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
20,760
-16.25%
|
$1,224,840
$59.84 P/Share
|
|
Apr 08
2025
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,760
+22.03%
|
$352,920
$17.08 P/Share
|
|
Mar 21
2025
|
Christopher Paul German Corporate Controller & CAO |
SELL
Open market or private sale
|
Direct |
344
-10.64%
|
$18,576
$54.23 P/Share
|
|
Mar 20
2025
|
Christopher Paul German Corporate Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,163
+26.46%
|
-
|
|
Mar 14
2025
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
75,000
-37.33%
|
$3,825,000
$51.26 P/Share
|
|
Mar 14
2025
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+39.4%
|
$1,650,000
$22.28 P/Share
|
|
Feb 19
2025
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,215
-1.98%
|
$126,255
$57.22 P/Share
|
|
Feb 19
2025
|
Christopher Paul German Corporate Controller & CAO |
SELL
Open market or private sale
|
Direct |
635
-23.48%
|
$36,195
$57.22 P/Share
|
|
Feb 19
2025
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
2,035
-25.78%
|
$115,995
$57.22 P/Share
|
|
Feb 19
2025
|
David P Meeker President and CEO |
SELL
Open market or private sale
|
Direct |
9,896
-4.69%
|
$564,072
$57.22 P/Share
|
|
Feb 19
2025
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
1,228
-12.61%
|
$69,996
$57.22 P/Share
|
|
Feb 19
2025
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
982
-4.86%
|
$55,974
$57.22 P/Share
|
|
Feb 16
2025
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+5.56%
|
-
|
|
Feb 16
2025
|
Christopher Paul German Corporate Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,807
+40.05%
|
-
|
|
Feb 16
2025
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+41.07%
|
-
|
|
Feb 16
2025
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+11.99%
|
-
|